Patent
   D358880
Priority
Dec 02 1993
Filed
Dec 02 1993
Issued
May 30 1995
Expiry
May 30 2009
Assg.orig
Entity
unknown
51
6
n/a
The ornamental design for a dry powder inhalator, as shown and described.

FIG. 1 is a top perspective view of the design for a dry powder inhalator;

FIG. 2 is a bottom perspective view of the design thereof;

FIG. 3 is a side view of the design thereof as seen from the right hand side of FIG. 1; and,

FIG. 4 is a rear view of the design thereof.

Pandorf, Robert, Lacotta, Paul, Mulhauser, Paul

Patent Priority Assignee Title
10130581, Feb 22 2006 MannKind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
10130685, Aug 23 2004 MannKind Corporation Diketopiperazine salts for drug delivery and related methods
10130709, Jun 17 2011 MannKind Corporation High capacity diketopiperazine microparticles and methods
10143655, Sep 14 2005 MannKind Corporation Method of drug formulation
10159644, Oct 26 2012 MannKind Corporation; TechnoVax, Inc. Inhalable vaccine compositions and methods
10172850, Dec 29 2008 MannKind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
10201672, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
10258664, Oct 24 2011 MannKind Corporation Methods and compositions for treating pain
10307464, Mar 27 2015 MannKind Corporation Use of ultrarapid acting insulin
10342938, Jun 13 2008 MannKind Corporation Dry powder drug delivery system
10421729, Mar 15 2013 MannKind Corporation Microcrystalline diketopiperazine compositions and methods
10561806, Oct 02 2014 MannKind Corporation Mouthpiece cover for an inhaler
10625034, Apr 01 2011 MannKind Corporation Blister package for pharmaceutical cartridges
10675421, Jun 20 2008 MannKind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
10751488, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
11446127, Aug 05 2013 MannKind Corporation Insufflation apparatus and methods
9192675, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9220687, Dec 29 2008 MannKind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
9233159, Oct 24 2011 MannKind Corporation; Torrey Pines Institute for Molecular Studies Methods and compositions for treating pain
9241903, Feb 22 2006 MannKind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
9283193, Sep 14 2005 MannKind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
9339615, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9364436, Jun 17 2011 MannKind Corporation High capacity diketopiperazine microparticles and methods
9364619, Jun 20 2008 MannKind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
9446001, Sep 14 2005 MannKind Corporation Increasing drug affinity for crystalline microparticle surfaces
9446133, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9511198, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9610351, Oct 24 2011 MannKind Corporation; Torrey Pines Institute for Molecular Studies Methods and compositions for treating pain
9630930, Jun 12 2009 MannKind Corporation Diketopiperazine microparticles with defined specific surface areas
9655850, Dec 29 2008 MannKind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
9662461, Jun 13 2008 MannKind Corporation Dry powder drug delivery system and methods
9675674, Aug 23 2004 MannKind Corporation Diketopiperazine salts for drug delivery and related methods
9700690, Mar 20 2002 MannKind Corporation Inhalation apparatus
9706944, Nov 03 2009 MannKind Corporation Apparatus and method for simulating inhalation efforts
9717689, Sep 14 2005 MannKind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
9796688, Aug 20 2004 MannKind Corporation Catalysis of diketopiperazine synthesis
9801925, Jun 29 1999 MannKind Corporation Potentiation of glucose elimination
9802012, Jul 12 2012 MannKind Corporation Dry powder drug delivery system and methods
9925144, Jul 18 2013 MannKind Corporation Heat-stable dry powder pharmaceutical compositions and methods
9943571, Aug 11 2008 MannKind Corporation Use of ultrarapid acting insulin
9983108, Mar 11 2009 MannKind Corporation Apparatus, system and method for measuring resistance of an inhaler
D379506, Jul 01 1995 Glaxo Group Limited Inhaler
D395499, Apr 08 1996 DURA PHARMACEUTICALS, INC Dry powder inhaler
D441859, Apr 06 1999 IVO PERA Disposable dry-powder inhaler
D604832, Jun 13 2008 MannKind Corporation Cartridge for a dry powder inhaler
D711529, Nov 02 2011 NANBU PLASTICS CO , LTD Device for administering drug solution
D767114, Mar 18 2015 Amneal Pharmaceuticals Company GmbH Inhalation device
D769439, Mar 18 2015 Amneal Pharmaceuticals Company GmbH Inhalation device
D943733, Apr 30 2020 APTAR RADOLFZELL GMBH Evaluation unit for inhalers
ER4517,
ER5099,
Patent Priority Assignee Title
4627432, Oct 08 1982 Glaxo Group Limited Devices for administering medicaments to patients
5042472, Oct 15 1990 Merck & Co., Inc.; MERCK & CO , INC A CORPORATION OF NEW JERSEY Powder inhaler device
5318016, Mar 30 1993 AVADEL PHARMACEUTICALS USA , INC Inhalation device
D282209, Jun 29 1983 Glaxo Group Limited Inhaler
D299066, Sep 16 1985 Glaxo Group Limited Inhalator
GB2061735,
/////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Nov 17 1993MULHAUSER, PAULTenax CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0068430581 pdf
Nov 17 1993LACOTTA, PAULTenax CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0068430581 pdf
Nov 17 1993PANDORF, ROBERTTenax CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0068430581 pdf
Dec 02 1993Tenax Corporation(assignment on the face of the patent)
Oct 24 1995Tenax CorporationGlaxo Wellcome IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0078460626 pdf
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule